Life Lessons and Safari Reflections with David Pivnick of McGuireWoods LLP 8-7-25
In this episode, David Pivnick shares stories and insights from a recent family trip to Africa, exploring the contrast between privilege and poverty, lessons from local communities, and the humbling perspective gained from time on safari.
When the Markets Surge, Don’t Double Down on Debt 8-7-25
In this episode, Scott Becker cautions against increasing debt or unchecked spending during market highs.
Great Recruiting is Everything 8-7-25
In this episode, Scott Becker highlights why landing the right people matters more than any business plan.
5 Quick Stories We Are Following Today 8-7-25
In this episode, Scott Becker shares five quick market updates, including Apple’s surge on tariff exemptions, DoorDash’s strong earnings, Lucid’s continued struggles, Astera Labs’ record high, and Six Flags’ steep decline.
Don’t Move the Goalpost: It’s Easier to Advise Than to Do 8-6-25
In this episode, Scott Becker discusses the common pitfall of constantly shifting business targets, highlighting how easy it is to offer advice while struggling to follow it yourself.
The Analytical vs. the Intuitive Brain 8-6-25
In this episode, Scott Becker reflects on the contrast between intuitive and analytical thinking, using examples from golf, soccer, and business.
Blackstone Returns to Greatness 8-6-25
This episode explores Blackstone’s rebound from early-year losses and its strategic push to attract top-tier talent.
14 Stories We Are Following Today 8-6-25
In this episode, Scott Becker shares 14 major business and financial headlines, including market trends, sharp moves from Snapchat and Palantir, a deep dive into the trade deficit, and more.
Regulatory Shifts, Deal Market Trends, and Strategic Focus in Healthcare with Holly Buckley of McGuireWoods LLP 8-5-25
In this episode, Holly Buckley, Chair of Healthcare at McGuireWoods, shares insights on key regulatory changes impacting healthcare private equity, current trends in the deal market, and her team’s focus areas for the remainder of the year, including life sciences and FDA-related growth.
hims & hers Misses Estimates 8-5-25
In this episode, Scott Becker discusses hims & hers seeing a stock dip despite strong annual growth after narrowly missing quarterly revenue expectations.